83 FR 10494 - Advisory Committee on Interdisciplinary, Community-Based Linkages

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Service Administration

Federal Register Volume 83, Issue 47 (March 9, 2018)

Page Range		10494-10494
FR Document		2018-04815

In accordance with the Federal Advisory Committee Act, notice is hereby given that two orientation meetings are scheduled for the Advisory Committee on Interdisciplinary, Community-Based Linkages (ACICBL). These meetings will be open to the public. Information about the ACICBL and the agenda for these meetings can be obtained by accessing the ACICBL website at: https://www.hrsa.gov/advisory- committees/interdisciplinary-community-linkages/meetings/index.html.

Federal Register, Volume 83 Issue 47 (Friday, March 9, 2018)

[Federal Register Volume 83, Number 47 (Friday, March 9, 2018)]
[Notices]
[Page 10494]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-04815]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Service Administration


Advisory Committee on Interdisciplinary, Community-Based Linkages

AGENCY: Health Resources and Service Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice of meetings.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, notice 
is hereby given that two orientation meetings are scheduled for the 
Advisory Committee on Interdisciplinary, Community-Based Linkages 
(ACICBL). These meetings will be open to the public. Information about 
the ACICBL and the agenda for these meetings can be obtained by 
accessing the ACICBL website at: https://www.hrsa.gov/advisory-committees/interdisciplinary-community-linkages/meetings/index.html.

DATES: In order to accommodate the schedules of the ACICBL members, two 
orientation meetings will be held. The first meeting will be on March 
15, 2018 from 11:00 a.m.-4:00 p.m., ET and the second meeting will be 
on March 27, 2018 from 12:00 p.m.-5:00 p.m., ET.

ADDRESSES: These meetings will be held via conference call/webinar.
     The teleconference call-in number is 1-800-619-2521, 
passcode: 9271697.
     The webinar link is https://hrsa.connectsolutions.com/acicbl.

FOR FURTHER INFORMATION CONTACT: Anyone requesting information 
regarding the ACICBL should contact Joan Weiss, Ph.D., RN, CRNP, FAAN, 
HRSA, in one of three ways: (1) Send a request to the following 
address: Joan Weiss, Ph.D., RN, CRNP, FAAN, Senior Advisor and 
Designated Federal Officer, Division of Medicine and Dentistry, HRSA, 
5600 Fishers Lane, Room 15N39, Rockville, Maryland 20857; (2) call 
(301) 443-0430; or (3) send an email to [email protected].

SUPPLEMENTARY INFORMATION: The ACICBL provides advice and 
recommendations on a broad range of issues relating to grant programs 
authorized by sections 750-760, Title VII, Part D of the Public Health 
Service Act. During the March 15, 2018 and March 27, 2018 meetings. 
ACICBL members will be oriented to the work of the Committee and 
identify potential topics to work on for 2018.
    The ACICBL's reports are submitted to the Secretary of HHS; the 
Committee on Health, Education, Labor, and Pensions of the U.S. Senate; 
and the Committee on Energy and Commerce of the U.S. House of 
Representatives.
    Members of the public will have the opportunity to provide 
comments. Oral comments will be honored in the order they are requested 
and may be limited as time allows. Requests to make oral comments or 
provide written comments to the ACICBL should be sent by March 13, 2018 
for the March 15, 2018 meeting and by March 25, 2018 for the March 27, 
2018 meeting.

Amy McNulty,
Acting Director, Division of the Executive Secretariat.
[FR Doc. 2018-04815 Filed 3-8-18; 8:45 am]
 BILLING CODE 4165-15-P

10494 Federal Register / Vol. 83, No. 47 / Friday, March 9, 2018 / Notices

purposes of §§ 314.161 and 314.162, DEPARTMENT OF HEALTH AND on Health, Education, Labor, and
never marketing an approved drug HUMAN SERVICES Pensions of the U.S. Senate; and the
product is equivalent to withdrawing Committee on Energy and Commerce of
the drug from sale. Health Resources and Service the U.S. House of Representatives.
Administration Members of the public will have the
Goodwin Procter LLP submitted a
citizen petition dated September 26, opportunity to provide comments. Oral
Advisory Committee on comments will be honored in the order
2017 (Docket No. FDA–2017–P–5946), Interdisciplinary, Community-Based they are requested and may be limited
under 21 CFR 10.30, requesting that the Linkages as time allows. Requests to make oral
Agency determine whether DORYX
AGENCY: Health Resources and Service comments or provide written comments
MPC (doxycycline hyclate), delayed- to the ACICBL should be sent by March
release tablets, 60 mg, were withdrawn Administration (HRSA), Department of
Health and Human Services (HHS). 13, 2018 for the March 15, 2018 meeting
from sale for reasons of safety or and by March 25, 2018 for the March 27,
effectiveness. ACTION: Notice of meetings.
2018 meeting.
After considering the citizen petition SUMMARY: In accordance with the Amy McNulty,
and reviewing Agency records and Federal Advisory Committee Act, notice
Acting Director, Division of the Executive
based on the information we have at this is hereby given that two orientation Secretariat.
time, FDA has determined under meetings are scheduled for the Advisory
[FR Doc. 2018–04815 Filed 3–8–18; 8:45 am]
§ 314.161 that DORYX MPC Committee on Interdisciplinary,
BILLING CODE 4165–15–P
(doxycycline hyclate), delayed-release Community-Based Linkages (ACICBL).
tablets, 60 mg, were not withdrawn for These meetings will be open to the
reasons of safety or effectiveness. The public. Information about the ACICBL DEPARTMENT OF HEALTH AND
petitioner has identified no data or other and the agenda for these meetings can HUMAN SERVICES
information suggesting that this drug be obtained by accessing the ACICBL
product was withdrawn for reasons of website at: https://www.hrsa.gov/ National Institutes of Health
safety or effectiveness. We have advisory-committees/interdisciplinary-
carefully reviewed our files for records community-linkages/meetings/ National Cancer Institute; Notice of
concerning the withdrawal of DORYX index.html. Closed Meetings
MPC (doxycycline hyclate), delayed- DATES: In order to accommodate the Pursuant to section 10(d) of the
release tablets, 60 mg, from sale. We schedules of the ACICBL members, two Federal Advisory Committee Act, as
have found no information that would orientation meetings will be held. The amended, notice is hereby given of the
indicate that this drug product was first meeting will be on March 15, 2018 following meetings.
withdrawn from sale for reasons of from 11:00 a.m.–4:00 p.m., ET and the The meetings will be closed to the
safety or effectiveness. second meeting will be on March 27, public in accordance with the
2018 from 12:00 p.m.–5:00 p.m., ET. provisions set forth in sections
Accordingly, the Agency will
ADDRESSES: These meetings will be held 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
continue to list DORYX MPC
(doxycycline hyclate), delayed-release via conference call/webinar. as amended. The grant applications and
• The teleconference call-in number the discussions could disclose
tablets, 60 mg, in the ‘‘Discontinued
is 1–800–619–2521, passcode: 9271697. confidential trade secrets or commercial
Drug Product List’’ section of the Orange
• The webinar link is https:// property such as patentable material,
Book. The ‘‘Discontinued Drug Product hrsa.connectsolutions.com/acicbl.
List’’ delineates, among other items, and personal information concerning
drug products that have been FOR FURTHER INFORMATION CONTACT: individuals associated with the grant
Anyone requesting information applications, the disclosure of which
discontinued from marketing for reasons
regarding the ACICBL should contact would constitute a clearly unwarranted
other than safety or effectiveness.
Joan Weiss, Ph.D., RN, CRNP, FAAN, invasion of personal privacy.
ANDAs that refer to this drug product HRSA, in one of three ways: (1) Send a
may be approved by the Agency as long Name of Committee: National Cancer
request to the following address: Joan Institute Special Emphasis Panel; NCI
as they meet all other legal and Weiss, Ph.D., RN, CRNP, FAAN, Senior Pediatric Early Phase Clinical Trials Network
regulatory requirements for the approval Advisor and Designated Federal Officer, (PEP–CTN).
of ANDAs. If FDA determines that Division of Medicine and Dentistry, Date: March 27, 2018.
labeling for this drug product should be HRSA, 5600 Fishers Lane, Room 15N39, Time: 11:00 a.m. to 2:00 p.m.
revised to meet current standards, the Rockville, Maryland 20857; (2) call Agenda: To review and evaluate grant
Agency will advise ANDA applicants to (301) 443–0430; or (3) send an email to applications.
submit such labeling. Place: National Cancer Institute, Shady
jweiss@hrsa.gov. Grove, 9609 Medical Center Drive, Room
Dated: March 5, 2018. SUPPLEMENTARY INFORMATION: The 7W538, Rockville, MD 20850, (Telephone
Leslie Kux, ACICBL provides advice and Conference Call).
recommendations on a broad range of Contact Person: Shamala K. Srinivas,
Associate Commissioner for Policy. Ph.D., Scientific Review Officer, Office of
issues relating to grant programs
[FR Doc. 2018–04726 Filed 3–8–18; 8:45 am] Referral, Review, and Program Coordination,
authorized by sections 750–760, Title
BILLING CODE 4164–01–P VII, Part D of the Public Health Service Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
amozie on DSK30RV082PROD with NOTICES

Act. During the March 15, 2018 and Drive, Room 7W530, Bethesda, MD 20892–
March 27, 2018 meetings. ACICBL 9750, 240–276–6430, ss537t@nih.gov.
members will be oriented to the work of Name of Committee: National Cancer
the Committee and identify potential Institute Special Emphasis Panel; U01 SEP:
topics to work on for 2018. Liquid Biopsy & Early Cancer Assessment.
The ACICBL’s reports are submitted Date: May 1, 2018.
to the Secretary of HHS; the Committee Time: 10:00 a.m. to 5:00 p.m.

VerDate Sep<11>2014 16:47 Mar 08, 2018 Jkt 244001 PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 E:\FR\FM\09MRN1.SGM 09MRN1

Document Created: 2018-03-09 03:48:33
Document Modified: 2018-03-09 03:48:33

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice of meetings.
Dates		In order to accommodate the schedules of the ACICBL members, two orientation meetings will be held. The first meeting will be on March 15, 2018 from 11:00 a.m.-4:00 p.m., ET and the second meeting will be on March 27, 2018 from 12:00 p.m.-5:00 p.m., ET.
Contact		Anyone requesting information regarding the ACICBL should contact Joan Weiss, Ph.D., RN, CRNP, FAAN, HRSA, in one of three ways: (1) Send a request to the following
FR Citation		83 FR 10494

83 FR 10494 - Advisory Committee on Interdisciplinary, Community-Based Linkages

DEPARTMENT OF HEALTH AND HUMAN SERVICESHealth Resources and Service Administration

Federal Register Volume 83, Issue 47 (March 9, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Service Administration